New insights: a natural small molecule isowalsuranolide targeting TrxR1/2 and triggering self-eating (autophagy) to combat cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 22-Aug-2025 21:11 ET (23-Aug-2025 01:11 GMT/UTC)
Lysosomes are considered as the major degradative site and were recently recognized as dynamic regulators of cellular homeostasis. Many diseases, including cancer, have been linked to functional changes in lysosomes. Natural products and their structural analogs have historically made major contributions to pharmacotherapy. By employing the natural small molecule isowalsuranolide as a chemical probe, the underlying mechanisms of its lysosome-inducing effects were investigated. This study revealed that isowalsuranolide targets TrxR1/2 and triggers lysosomal biogenesis and autophagy via the p53-TFEB/TFE3 axis. This study provides important insight into the lysosomal adaptation mechanism to redox signals and the application of lysosome-inducing agents in the treatment of lysosome-related diseases, including cancer.
Article about Dr. Leeat Keren’s research, Dept. of Molecular Cell Biology, on CombPlex—an AI-assisted method that enables imaging dozens of proteins in tissue samples at once, offering a new, scalable tool for biomedical research and clinical diagnostics